Hovione Expands Spray Drying Capabilities with $100 Million Investment in New Jersey

Hovione, a leading contract manufacturer in the pharmaceutical industry, has significantly boosted its production capacity by more than doubling spray drying operations at its East Windsor, New Jersey campus. The expansion includes an additional 31,000 square feet of manufacturing space, part of a $100 million project aimed at handling more complex drug products.

CEO Jean Luc Herbeaux highlighted the strategic importance of the move, stating, “This investment reinforces Hovione’s leadership in spray drying – a core technology platform where we have built extensive know-how and capabilities. By advancing our unique technology platforms and expanding our U.S. capacity, we are strengthening the foundation that enables our partners to bring complex medicines to patients more efficiently.”

The upgrade positions Hovione to meet growing demand for advanced pharmaceutical manufacturing, enhancing its role in supporting innovative drug development.